UPC APP 25212/2025

—·EP2279254 +1 more: NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
Genevant Sciences GmbH
Arbutus Biopharma Corporation
Reps: Markus van Gardingen
Respondents
Moderna, Inc.
ModernaTX, Inc.
Moderna Switzerland GmbH
Moderna Netherlands B.V.
Moderna Biotech Spain SL
Moderna Germany GmbH
Moderna France SASU
Moderna Italy S.R.L.
Moderna Belgium S.R.L.
Moderna Denmark ApS
Moderna Sweden AB
Moderna Norway AS
Moderna Portugal Unipessoal LDA
Moderna Poland SP. Z.O.O.
Moderna Biotech UK Limited
Reps: Ruben Laddé; Joachim Renken
Division: The Hague LD
Judges: Margot Kokke · Judge-rapporteur
Technology: Biotechnology
Language: —
First decided: Jun 4, 2025

Decisions

2025-06-04
Generic application
The Hague Local Division issued a rectification order under R.353 RoP correcting clerical errors in a prior procedural order regarding the dates of service on Moderna Germany, Belgium, and Poland, thereby rendering Moderna's preliminary objections admissible for all defendants in infringement actions concerning EP2279254 and EP4241767.
Legal issues:Rectification of order (R.353 RoP)Clerical errors in date of serviceAdmissibility of preliminary objectionsTime limit for preliminary objections

Documents